Healthcare Management Professional Driving Innovation and Efficiency in Medical Functional Diagnostics, Digital Medicine, E-Health, Health Economics, Health Tech Management, Health Business Administration
Understanding the nuances of treatment response in severe COPD is crucial. Beyond radiological outcomes and lung function improvements, patient perception is paramount. Recent studies suggest a TLVR >50% leads to meaningful outcomes, complemented by exercise capacity and quality of life measures. Let's prioritize holistic patient-centered care in COPD management.
Vorstand der Abteilung für Innere Medizin und Pneumologie, Leiter des Karl-Landsteiner-Instituts für Lungenforschung und Pneumologische Onkologie, Klinik Floridsdorf
Severe emphysema is a debilitating disease. Patients with severe COPD characterized by emphysema and hyperinflation may, however, be eligible for bronchoscopic lung volume reduction therapy with one-way endobronchial valves (EBV therapy), an established treatment for many years now. This review proposes a management strategy for when there is poor response to EBV therapy and is thus a must read for all users and those who are interested in establishing an EBV service at their institutions. As always a pleasure to work with a panel of international experts, in order to further move this important technology and #interventionalpulmonology forward. congrats to David Koster Dirk-Jan Slebos Pallav Shah Felix JF Herth Michael Perch D. Kyle Hogarth, MD, FCCP Richard Sue Jonathan Kurman Douglas Wood and many more thank you Pulmonx Corporation and Narinder Singh Shargill, PhD https://lnkd.in/dzu9q_K7
